Murdock, Richard D.

▪ 1998

      In 1997 Rick Murdock, CEO of CellPro, Inc., a small biotechnology firm based in Bothell, Wash., was in the midst of a battle for the company that had saved his life. In late 1995 the then 48-year-old Murdock, a successful executive with no family history of cancer, found lumps in his neck and groin. He was eventually diagnosed with advanced mantle cell lymphoma, a rare and deadly form of cancer. Murdock needed to find a treatment, and fast—the average life expectancy following such a diagnosis was only about 30 months. Fortunately, he had an advantage not afforded others in his position; his best hope for a cure was right in his own backyard.

      At the time Murdock announced his condition, CellPro, founded in 1989, was working on cell separation technology that it hoped would improve the outcome of bone marrow transplants, which were used to treat a variety of cancers, including mantle cell lymphoma. Because Murdock's cancer was so advanced, the project was given top priority, and within a couple of months his researchers believed that they had found a viable treatment. The U.S. Food and Drug Administration granted CellPro a "compassionate use exemption," which allowed the company to test the new treatment on Murdock in June 1996. It was a success; within a month after Murdock completed the procedure, test results revealed that he was free of cancer.

      During 1997 it was too soon for Murdock's doctors to consider him cured, but his prognosis appeared good. The future of CellPro, however, was less certain. The company was involved in an ongoing patent-infringement lawsuit brought by Johns Hopkins University, Baltimore, Md.; Baxter International, Inc.; and Becton Dickinson & Co. concerning an antibody used in the treatment that had given Murdock his second chance. In March 1997 a federal district court jury ruled in favour of the plaintiffs, and CellPro was ordered to pay $2.3 million in damages. The company was hit even harder in July 1997 when a judge upheld the jury's decision and increased the amount of the damages to some $7 million.

      Murdock was born March 21, 1947, in Martinez, Calif. In 1969 he received a bachelor's degree in zoology from the University of California, Berkeley. Following graduation he held positions in sales and marketing, and from 1989 to 1991 he was European vice president of the Fenwal Division of Baxter Healthcare Corp. He began at CellPro as vice president of marketing and corporate development in September 1991, and by 1992 he had become president of the company. From June 1992 he also held the positions of CEO and director.

SANDRA LANGENECKERT

* * *